| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |